LOVEGRA ORAL JELLY
- Manufacturer:
- Ajanta
- Active ingredient
- Sildenafil Citrate
- Dosage
- 100 mg
- Best before date
- Until 2026-2027
- Reception
- 1 hour before the act
- Time of action
- Up to 5-6 hours
- Daily dose
- 100 mg
- Compatibility with alcohol
- No
Available product types:
What is LOVEGRA ORAL JELLY?
LOVEGRA ORAL JELLY is an oral jelly product containing sildenafil, positioned to support sexual function in women. The drug belongs to phosphodiesterase type 5 inhibitors — substances that, under certain conditions, dilate blood vessels and increase local blood circulation. It is assumed that blood flow to the pelvic organs can increase the sensitivity of sexual tissues and promote natural lubrication. At the same time, sildenafil does not create sexual desire on its own and does not replace treatment for psychological, hormonal, or gynecological causes of dysfunction.
The gel form is packaged in single-use sachets and is intended for oral administration. Compared to tablets, the jelly does not need to be swallowed whole, which can be convenient for people with swallowing difficulties. The speed of onset of the effect depends on food, dose, concomitant diseases, and the body's individual response. The presence of flavorings or sweeteners should be checked on the packaging of a specific batch.
The pharmaceutical company Ajanta Pharma is indicated as the manufacturer of LOVEGRA ORAL JELLY. The use of sildenafil by women has varying regulatory status in different countries and is often not among the standardly approved treatments for female sexual dysfunction. Therefore, before starting use, a doctor's consultation is necessary to assess potential benefits, cardiovascular risks, and compatibility with other drugs. Self-treatment is especially dangerous in the presence of heart disease, unstable blood pressure, or ongoing drug therapy.
What is LOVEGRA ORAL JELLY prescribed for?
LOVEGRA ORAL JELLY may be considered by a doctor for complaints of insufficient physiological response of sexual tissues during arousal. Such manifestations include reduced genital sensitivity, insufficient tissue swelling, and difficulty with natural lubrication. The expected effect is associated with increased blood flow, rather than a direct increase in libido. For the drug to work, sexual stimulation, comfortable conditions, and the absence of severe pain are usually required.
The product is sometimes used in the comprehensive management of female sexual dysfunction if the doctor considers the vascular component clinically significant. Problems with orgasm, dryness, or decreased desire can be associated with menopause, depression, side effects of antidepressants, endocrine disorders, or relationship conflicts. LOVEGRA ORAL JELLY does not eliminate all of these causes and is not a universal drug for female libido. Diagnosing the cause of the symptoms is more important than attempting to temporarily enhance the physiological response.
Prescription may be justified only after evaluating complaints, duration of symptoms, concomitant medications, and overall health. For vaginal dryness, the doctor may recommend lubricants, moisturizers, or other therapy depending on the cause. If pain occurs during sexual intercourse, a gynecological examination is required, as masking the symptom may delay correct treatment. The efficacy and tolerability of sildenafil vary in each woman due to individual body response.
Composition and active components of LOVEGRA ORAL JELLY
The active component of LOVEGRA ORAL JELLY is sildenafil, usually presented as citrate salt. The exact amount of the active substance in one sachet must be verified with the original packaging and instructions, as product specifications may vary depending on the market. Sildenafil inhibits the enzyme phosphodiesterase type 5 and slows down the breakdown of cyclic guanosine monophosphate. In simple terms, this mechanism helps the smooth muscles of the vessels relax and can increase blood filling of tissues in the presence of sexual stimulation.
Excipients form the jelly-like consistency, taste, aroma, and stability of the product, but do not provide the main pharmacological action by themselves. The composition may include water, sweeteners, thickeners, acidity regulators, preservatives, colorings, and flavorings. The full list should be checked in the instructions of the specific batch, especially in case of allergies, diabetes mellitus, or intolerance to individual sweeteners. A damaged sachet, unclear labeling, or mismatch in composition is a reason not to use the product.
Dosage of LOVEGRA ORAL JELLY
The dose of LOVEGRA ORAL JELLY is determined individually by a doctor, as there is no generally accepted universal regimen of sildenafil for female sexual dysfunction. You should not automatically take the entire sachet without checking the sildenafil content and the prescribed amount. The doctor usually chooses the lowest effective dose, taking into account age, blood pressure, liver and kidney function, and concomitant therapy. Increasing the dose on your own does not guarantee a better result, but increases the risk of headaches, hot flashes, and a drop in blood pressure.
The product is intended for situational, rather than uncontrolled daily use, unless another regimen is explicitly established by a specialist. Repeated intake within the same day without medical instruction is unacceptable. The duration of use is determined after assessing the effect and adverse reactions, and in the absence of benefit, the regimen is reviewed. Patients with severe hepatic or renal impairment may require a lower dose or complete discontinuation of the drug.
How to take LOVEGRA ORAL JELLY correctly?
LOVEGRA ORAL JELLY is taken orally approximately 30–60 minutes before anticipated sexual activity, unless otherwise recommended by a doctor. The contents of the sachet or the prescribed amount is squeezed into the mouth and swallowed, without mixing with other medicines. Very fatty food can slow down the absorption of sildenafil and delay the expected effect. The action does not occur automatically: sexual stimulation and a favorable emotional context are required.
Since the drug is used as needed, the concept of a missed dose is usually not relevant. You cannot compensate for an untimely intake with a double amount or repeat the dose because the effect did not occur immediately. Do not combine the product with other sildenafil preparations or drugs for erectile dysfunction. Before taking LOVEGRA ORAL JELLY for the first time, a doctor's consultation and a check of all constantly used medications are mandatory.
Side effects of LOVEGRA ORAL JELLY
Common side effects of sildenafil include headache, facial flushing, hot flashes, nasal congestion, heartburn, nausea, and dizziness. Temporary blurred vision, increased sensitivity to light, or changes in color perception are possible. The intensity of symptoms often depends on the dose, but it is impossible to predict the reaction of a specific person. If adverse events are pronounced or repeated, further intake is stopped until consulting a doctor.
Palpitations, blood pressure fluctuations, vomiting, rash, eye pain, or nosebleeds occur uncommonly. Immediate medical attention is required for chest pain, fainting, difficulty breathing, facial swelling, or signs of a severe allergy. Sudden loss or sharp deterioration of vision or hearing also require urgent discontinuation of use and seeking help. Any prolonged painful swelling of genital tissues should be regarded as a reason for an urgent examination.
Contraindications of LOVEGRA ORAL JELLY
An absolute contraindication is an allergy to sildenafil or any excipient. LOVEGRA ORAL JELLY must not be combined with nitrates, including nitroglycerin, isosorbide mononitrate or dinitrate, due to the risk of a dangerous drop in blood pressure. Simultaneous use with nitric oxide donors and guanylate cyclase stimulants, such as riociguat, is also prohibited. The drug is not used in conditions where sexual activity is contraindicated due to severe or unstable cardiovascular disease.
Caution is required in case of low blood pressure, uncontrolled hypertension, arrhythmias, recent heart attack or stroke, severe liver and kidney diseases. Bleeding disorders, active peptic ulcer disease, anatomical changes in the genitals, and hereditary retinal diseases require separate evaluation. The product is not recommended for pregnant and breastfeeding women due to the lack of sufficient safety data and the absence of appropriate indications. LOVEGRA ORAL JELLY is not intended for children and adolescents, and the dose for elderly patients is selected with particular caution.
Interaction of LOVEGRA ORAL JELLY with other drugs and alcohol
The most dangerous is the interaction of LOVEGRA ORAL JELLY with nitrates and riociguat, which can cause critical hypotension. Alpha-blockers and certain antihypertensive drugs can also increase dizziness and a drop in blood pressure. Sildenafil levels can be increased by some antifungal drugs, macrolide antibiotics, drugs against human immunodeficiency virus, and grapefruit juice. The doctor must be informed of all prescription and over-the-counter medicines, herbal remedies, and dietary supplements.
Alcohol can increase headaches, hot flashes, dizziness, and decreased blood pressure, and a significant amount of it impairs sexual response. It is safest to avoid alcohol or limit its use in accordance with the doctor's recommendation. In case of dizziness, visual impairment, or weakness, you must not drive vehicles, operate machinery, or perform potentially dangerous tasks. Even after previous good tolerance, the body's reaction during the next intake may differ.
Where to buy LOVEGRA ORAL JELLY in Ukraine
You can buy LOVEGRA ORAL JELLY in Ukraine only taking into account the current status of state registration, prescription dispensing rules, and doctor's recommendation. Availability should be checked in licensed pharmacies or official pharmacy services, avoiding sellers without documents on the origin and quality of the goods. Upon receiving delivery, it is necessary to inspect the packaging, batch number, expiration date, integrity of the sachets, and data of the manufacturer Ajanta Pharma. A suspiciously low price, errors in labeling, or the absence of instructions may indicate a counterfeit.
Store LOVEGRA ORAL JELLY in its original packaging in accordance with the temperature specified in the instructions, in a dry place out of direct sunlight. The drug must be kept out of reach of children and must not be frozen or overheated during transport. An expired, damaged, or improperly stored product must not be used. The informational description does not replace medical consultation: the decision on intake, dose, and duration of use is made by a doctor, taking into account the individual response of the body.




































/tadaflo-5-tabletki-kupyty-v-ukraine-127-228x228.jpg)




















